Biomarkers for Screening and Diagnosis of Heart Failure in Cardiovascular-Kidney-Metabolic Syndrome: A Narrative Review - PubMed
5 hours ago
- #biomarkers
- #cardiovascular-kidney-metabolic-syndrome
- #heart-failure
- Cardiovascular-kidney-metabolic syndrome is a new concept highlighting interactions between cardiovascular, kidney, and metabolic systems.
- Early detection of cardiovascular dysfunction is crucial due to the rising prevalence of poor cardiovascular-kidney-metabolic health.
- Heart failure is common in patients with chronic kidney disease and metabolic risk factors, but screening and diagnosis remain challenging.
- Current guidelines recommend prediction scores and biomarker-based strategies for high-risk patients.
- Natriuretic peptides are widely used biomarkers but have limitations in cardiovascular-kidney-metabolic syndrome.
- Emerging biomarkers reflecting heart failure mechanisms are gaining attention.
- This review evaluates screening and diagnostic approaches for heart failure in cardiovascular-kidney-metabolic syndrome.
- Future research should focus on validating biomarkers and developing multimarker prediction scores to improve clinical outcomes.